Globe Life (NYSE:GL) Announces Earnings Results

Globe Life (NYSE:GL) posted its quarterly earnings data on Wednesday. The company reported $3.43 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.46 by ($0.03), FiscalAI reports. The firm had revenue of $1.56 billion for the quarter, compared to analysts’ expectations of $1.56 billion. Globe Life had a return on equity of 21.30% and a net margin of 19.37%.Globe Life’s revenue was up 5.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $3.07 earnings per share. Globe Life updated its FY 2026 guidance to 15.400-15.90 EPS.

Globe Life Trading Up 0.3%

NYSE GL opened at $151.36 on Thursday. The stock has a market capitalization of $11.87 billion, a price-to-earnings ratio of 10.75 and a beta of 0.47. Globe Life has a one year low of $111.13 and a one year high of $152.80. The company has a debt-to-equity ratio of 0.39, a current ratio of 0.07 and a quick ratio of 0.07. The business’s fifty day moving average is $143.31 and its 200-day moving average is $139.29.

Globe Life Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 1st. Stockholders of record on Friday, April 3rd will be paid a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Thursday, April 2nd. This is a positive change from Globe Life’s previous quarterly dividend of $0.27. Globe Life’s dividend payout ratio (DPR) is presently 9.38%.

Wall Street Analyst Weigh In

GL has been the topic of a number of analyst reports. Texas Capital raised shares of Globe Life to a “strong-buy” rating in a report on Wednesday, March 18th. Piper Sandler raised shares of Globe Life to a “strong-buy” rating in a report on Thursday, April 2nd. JPMorgan Chase & Co. lifted their price objective on shares of Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Evercore set a $157.00 price objective on shares of Globe Life in a report on Wednesday, February 18th. Finally, Wells Fargo & Company lifted their target price on Globe Life from $171.00 to $172.00 and gave the stock an “overweight” rating in a research note on Friday, April 10th. Two research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $172.11.

Insider Activity at Globe Life

In related news, CEO James Matthew Darden sold 18,318 shares of the business’s stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $145.10, for a total value of $2,657,941.80. Following the sale, the chief executive officer directly owned 51,093 shares in the company, valued at approximately $7,413,594.30. The trade was a 26.39% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Mark A. Blinn sold 1,750 shares of the business’s stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $147.91, for a total value of $258,842.50. Following the completion of the sale, the director owned 3,372 shares in the company, valued at $498,752.52. This represents a 34.17% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 82,807 shares of company stock worth $12,041,286. 2.11% of the stock is owned by company insiders.

Institutional Investors Weigh In On Globe Life

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Compound Planning Inc. raised its stake in Globe Life by 4.3% in the 4th quarter. Compound Planning Inc. now owns 1,968 shares of the company’s stock valued at $275,000 after acquiring an additional 82 shares during the period. Parallel Advisors LLC raised its stake in Globe Life by 5.6% in the 4th quarter. Parallel Advisors LLC now owns 1,651 shares of the company’s stock valued at $231,000 after acquiring an additional 87 shares during the period. Laird Norton Wetherby Wealth Management LLC raised its stake in Globe Life by 2.2% in the 3rd quarter. Laird Norton Wetherby Wealth Management LLC now owns 4,518 shares of the company’s stock valued at $646,000 after acquiring an additional 99 shares during the period. Cetera Investment Advisers raised its stake in Globe Life by 1.3% in the 4th quarter. Cetera Investment Advisers now owns 8,861 shares of the company’s stock valued at $1,239,000 after acquiring an additional 113 shares during the period. Finally, Transamerica Financial Advisors LLC raised its stake in Globe Life by 46.0% in the 4th quarter. Transamerica Financial Advisors LLC now owns 543 shares of the company’s stock valued at $76,000 after acquiring an additional 171 shares during the period. 81.61% of the stock is currently owned by institutional investors.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.